Use of dry powder inhalers in acute exacerbations of asthma and COPD

Therapeutic Advances in Respiratory Disease

Volumn 3, Issue 2, 2009, Pages 81-91

  Selroos, Olof ^a   Borgström, Lars ^b   Ingelf, Jarl ^b  

^a Semeco AB ^*  (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

asthma; COPD; DPI; Dry powder inhaler; exacerbation; hospitalization; Turbuhaler; worsening

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE PLUS FORMOTEROL; FORMOTEROL; SALBUTAMOL; TERBUTALINE;

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DRY POWDER; FORCED EXPIRATORY VOLUME; HUMAN; INTERMETHOD COMPARISON; MEDICAL NEBULIZER; METERED DOSE INHALER; OUTCOME ASSESSMENT; POWDER INHALER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT OUTCOME;

ADRENERGIC BETA-AGONISTS; ALBUTEROL; ASTHMA; BRONCHODILATOR AGENTS; DISEASE PROGRESSION; ETHANOLAMINES; HUMANS; NEBULIZERS AND VAPORIZERS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TERBUTALINE; TREATMENT OUTCOME;

EID: 67449142578     PISSN: 17534658     EISSN: None     Source Type: Journal    
DOI: 10.1177/1753465809103737     Document Type: Review

References (27)

1. Balanag, V.M., Yunus, F., Yang, P.-C. and Jorup, C. (2006) Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma. Pulm Pharmacol Ther 19: 139-147.
2. Boonsawat, W., Charoenratanakul, S., Pothirat, C., Sawanyawisuth, K., Seearamroongruang, T., Bengtsson, T. et al. (2003) Formoterol (OXIS®) Turbuhaler® as a rescue therapy compared with salbutamol pMDI plus spacer in patients with acute severe asthma. Respir Med 97: 1067-1074.
3. Borgström, L. (2001) On the use of dry powder inhalers in situations perceived as constrained. J Aerosol Med 14: 281-287.
4. Broeders, M.E.A.C., Molema, J., Hop, W.C.J., Vermue, N.A. and Folgering, H.T.M. (2004) The course of inhalation profiles during an exacerbation of obstructive lung disease. Respir Med 98: 1173-1179.
5. Cazzola, M., D'Amato, M., Califano, C., Di Perna, F., Calderaro, F., Matera, M.G. et al. (2002) Formoterol as dry powder oral inhalation compared with salbutamol metered-dose inhaler in acute exacerbations of chronic obstructive pulmonary disease. Clin Ther 24: 595-604.
6. Cazzola, M., Salzillo, A., De Giglio, C., Noschese, P. and D'Amato, G. (2003) Formoterol/budesonide (FBC) in the treatment of acute exacerbation of COPD. Eur Respir J 22(Suppl. 45): 288s, P1859.
7. Chuchalin, A., Makarova, I. and Bergqvist, P. (2003) As-needed formoterol has an improved safety profile compared with as-needed terbutaline in mild intermittent asthma. Eur Respir J 22(Suppl. 45): 235s, P1571.
8. Cordova, E.R. and Accinelli, R.A. (2004) Formoterol-Turbuhaler vs albuterol-MDI in adults with acute asthma in the emergency room. Am J Respir Crit Care Med 2004; 169(Suppl.): A313.
9. Drblik, S., Lapierre, G., Thivierge, R., Turgeon, J., Gaudreault, P., Cummins-McManus, B. et al. (2003) Comparative efficacy of terbutaline sulphate delivered by Turbuhaler dry powder inhaler or pressurised metered dose inhaler with Nebuhaler spacer in children during an acute asthmatic episode. Arch Dis Child 88: 319-323.
10. Freedman, B.J. (1972) Trial of a terbutaline aerosol in the treatment of asthma and a comparison of its effects with those of a salbutamol aerosol. Br J Dis Chest 66: 222-229.
11. Global Initiative for Asthma (2007) Global strategy for asthma management and prevention. Updated 2007. Available at: www.ginasthma.com, accessed September 2008.
12. Global Initiative for Chronic Obstructive Lung Disease (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2007. Available at: www.goldcopd.com, accessed September 2008.
13. Green, R., Clay, M. and Woodcock, A. (1996) The Accuhaler/Diskus inhaler for delivering salbutamol during bronchoconstriction. Am J Respir Crit Care Med 153: A61.
14. Grunfeld, A., Shragge, D.L., Dent, J.M., Soliman, S., Svensson, K.J. and Fitzgerald, J.M. (1996) Greater bronchodilation from Bricanyl Turbuhaler over Bricanyl pressurized metered dose inhaler in patients with acute asthma in the emergency department. Am J Respir Crit Care Med 153: A61.
15. Jonkers, R.E., Bantje, T.A. and Aalbers, R. (2006) Onset of relief of dyspnoea with budesonide/ formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study. Respir Res 7: 141.
16. Juniper, E.F., Svensson, K., Mork, A-C. and Stahl, E. (2004) Measuring health-related quality of life in adults during an acute asthma exacerbation. Chest 125: 93-97.
17. Lindmark, B. (2008) Differences in the pharmacodynamics of budesonide/formoterol and salmeterol/ fluticasone reflect differences in their therapeutic usefulness in asthma. Ther Adv Respir Dis 2: 279-299.
18. McNeill, R.S., Malcolm, G.D. and Rhind Brown, W. (1959) A comparison of expiratory and inspiratory flow rates in health and in chronic pulmonary disease. Thorax 14: 225-231.
19. Nana, A., Youngchaiyud, P., Charoenratanakul, S., Boe, J., Lofdahl, C.G., Selroos, O. et al. (1998) High-dose inhaled budesonide may substitute for oral therapy after an acute asthma attack. J Asthma 35: 647-655.
20. Pauwels, R.A., Sears, M.R., Campbell, M., Villasante, C., Huang, S., Lindh, A. et al. (2003) Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial. Eur Respir J 22: 787-794.
21. Phanareth, K. and Laursen, L.C. (1999) Bricanyl Turbuhaler versus nebuliser in the treatment of patients with acute severe airways obstruction. Eur Respir J 14(Suppl. 30): 61s.
22. Richter, K. (2004) Successful use of DPI systems in asthmatic patients - key parameters. Respir Med 98(Suppl. B): S22-S27.
23. Rubinfeld, A.R., Scicchitano, R., Hunt, A., Thompson, P.J., Van Nooten, A. and Selroos, O. (2006) Formoterol Turbuhaler® as reliever medication in patients with acute asthma. Eur Respir J 27: 735-741.
24. Seberova, E. and Andersson, A. (2000) Oxis (formoterol given by Turbuhaler) showed as rapid an onset of action as salbutamol given by a pMDI. Respir Med 94: 607-611.
25. Sole, D., Rizzo, M.C.F.V., Pimentel, A.F., Sano, F., Barreto, B.A., Wandalsen, N.F. et al. (1995) Effect of inhaled terbutaline sulphate (dry powder, Turbuhaler(TM) and nebulizer solution) in children with acute asthma. Jornal de Pediatria 71: 82-87.
26. Springer, C., Stahl, E., Schachter, J. and Avital, A. (1996) Terbutaline given via Turbuhaler and in nebulised form in children with acute asthma. Eur J Clin Res 8: 163-169.
27. van den Broek, K.M., Wielders, P.L.M.L., Creemers, J.P.H.M. and Smeenk, F.W.J.M. (2008) Efficacy of formoterol Turbuhaler in the emergency treatment of patients with obstructive airway diseases. Respir Med 102: 579-585.